A new study published in Nature Communications reveals that two mouse models, cuprizone (CPZ) and lysophosphatidylcholine (LPC), offer distinct insights into myelin loss and regeneration relevant to multiple sclerosis research. This comparative analysis helps researchers choose the most appropriate model for studying specific aspects of MS, advancing potential treatments focused on myelin repair and immune response modulation.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





